Yarrow Bioscience Inc
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $24.0M | $19.9M | $30.6M | $30.9M | $42.3M | $57.6M | $43.8M | $27.9M |
| Accounts Receivable | — | — | — | $173.0K | $7.6M | $15.8M | $135.0K | — |
| Inventory | — | — | — | — | $7.3M | $7.4M | $1.4M | — |
| Total Current Assets | $30.0M | $64.4M | $96.0M | $38.3M | $63.2M | $87.3M | $76.4M | $139.5M |
| Property, Plant & Equipment | $90.0K | $113.0K | $0 | $0 | $354.0K | $555.0K | $2.9M | $146.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $30.2M | $66.9M | $97.7M | $40.8M | $67.0M | $93.7M | $81.2M | $139.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $2.7M | $1.7M | $2.4M | $6.5M | $4.8M | $3.8M | $3.3M |
| Total Current Liabilities | $2.4M | $14.8M | $7.5M | $9.3M | $18.4M | $21.8M | $29.3M | $9.5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $33.2M | $32.7M | — |
| Total Liabilities | $2.4M | $14.8M | $9.0M | $9.3M | $18.4M | $56.2M | $63.6M | $9.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-757.7M | $-731.2M | $-691.3M | $-662.7M | $-639.5M | $-566.2M | $-310.6M | $-110.6M |
| Total Stockholders' Equity | $27.8M | $52.1M | $88.7M | $31.2M | $48.6M | $37.5M | $17.6M | $92.2M |